On verge of $13B merger, Valeant and Actavis stop talking
Valeant Pharmaceuticals was on the verge of its...
Read more
Read more
Archive for the 'valeant' tag
Merz drops out of Obagi bidding, handing $417M deal to Valeant
Merz Pharma's attempt to hijack Obagi Medical...
Read more
Read more
Valeant fires back at Merz with $415M-plus Obagi bid
Apparently, investors were right about Obagi...
Read more
Read more
Pearson says Valeant’s debt load not a worry
Valeant Pharmaceuticals' ( $VRX) has snapped...
Read more
Read more
Amid buyout chatter, Endo taps Valeant exec as CEO
Incoming Endo CEO Rajiv De Silva Will the talk of...
Read more
Read more
Report: Endo, in a world of hurt, may be looking for a savior
Endo Health Solutions' ( $ENDP ) is feeling...
Read more
Read more
Valeant chief shoots for $10B in sales–and then $20B
Valeant CEO J. Michael Pearson–courtesy of...
Read more
Read more
Valeant cuts 200 Medicis jobs as $2.6B deal closes
Valeant Pharmaceuticals ( $VRX ) isn't...
Read more
Read more
Teva, Valeant see earnings rise but profits hurt by one-time costs
Generics giant Teva Pharmaceutical Industries saw...
Read more
Read more
Teva, Takeda boost profits as Valeant swings to loss
Teva Pharmaceutical Industries ( $TEVA ) is the...
Read more
Read more
Pharma dealmakers, the price is right for Sweden’s Meda
Attention pharma shoppers: Meda AB is a...
Read more
Read more
Another day, another deal for Valeant’s Pearson
Valeant Pharmaceuticals ( $VRX ) made the...
Read more
Read more
Valeant nabs Russia’s Natur Produkt for $175M-plus
We sound like a broken record when it comes to...
Read more
Read more
Valeant counts itself out of ISTA’s strategic options
Valeant Pharmaceuticals CEO Michael Pearson has...
Read more
Read more
Valeant targets $200M in post-merger cost cuts
Whether Valeant Pharmaceuticals’ ( $VRX )...
Read more
Read more
Which pharmas win the hedge-fund popularity contest?
You know the proverb: A man is known by the...
Read more
Read more
ISTA rebuffs Valeant bid
Well, that was quick. Executives at ISTA...
Read more
Read more
Hungry for ISTA, Valeant makes bid
Canada’s Valeant Pharmaceutical ( $VRX )...
Read more
Read more
Paladin, Valeant raise stakes in bidding for Afexa
Canada’s Afexa Life Sciences has sparked a...
Read more
Read more
Valeant emerges as Afexa’s $76M white knight
Sorry, Paladin Labs. Valeant Pharmaceuticals (...
Read more
Read more
A.M. Vitals: Valeant Has Approached Meda About a Takeover
Takeover Talks?: Valeant Pharmaceuticals has...
Read more
Read more
Sources: Valeant eyes Meda for potential $4.4B deal
Valeant Pharmaceuticals is on the hunt again. The...
Read more
Read more
Valeant aims for top of dermatology, CEO says
No, you don’t have double vision. Valeant...
Read more
Read more
Valeant snaps up Sanofi’s Dermik for $425M
Sanofi ( $SNY ) has agreed to offload its Dermik...
Read more
Read more
FDA tags new GSK-Valeant med as controlled substance
GlaxoSmithKline and Valeant Pharmaceuticals can...
Read more
Read more